Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways

Overview of attention for article published in Journal of Biomedical Science, September 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Transcriptomic analysis reveals Cilostazol's role in ameliorating cardiovascular disease: Inhibition of monocyte-to-macrophage differentiation and reduction of endothelial cell reactive oxygen species production

Article in Heliyon (April 2024)

FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway.

Article in Acta Biochimica et Biophysica Sinica (March 2024)

A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches

Article in Diabetes Therapy (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.